Table 1.
Pharmacological manipulations affecting social and repetitive behavior in the BTBR T+Itpr3tf/J mouse.
Manipulation | Mechanism | Social interaction | Self-grooming | Marble burying | Other tests | Reference | |
---|---|---|---|---|---|---|---|
Excitatory/Inhibitory imbalance |
2-Methyl-6-(phenylethynyl)
pyridine (MPEP) |
selective mGluR5 antagonist | = |
![]() |
Silverman et al. 2010a | ||
![]() |
Burket et al 2011 | ||||||
Object location memory ![]() |
Seese et al. 2014 | ||||||
MWM ![]() Rotarod ![]() |
Yang et al. 2015 | ||||||
GRN-529 | selective negative allosteric modulator of the mGluR5 receptor |
![]() ![]() |
![]() |
Silverman et al. 2012 | |||
D-cycloserine | partial glycineB site agonist targeting NMDAR |
![]() |
![]() |
Rearing ![]() |
Burket et al. 2013 | ||
CX1837, CX1739 and CX546 | AMPAKINEs |
![]() |
= | OF = (except for CX546, which caused
sedation) CX1837 ![]() |
Silverman et al. 2013 | ||
CX929 | AMPAKINE | Object location memory = | Seese et al. 2014 | ||||
Diazepam | positive allosteric modulator of GABAA receptors |
![]() |
Pobbe et al. 2011 | ||||
![]() |
Defensor et al 2011 | ||||||
EPM arm entries ![]() |
Kazdoba et al. 2016 | ||||||
Diazepam at P15–28 | Multi-sensory integration ![]() |
Gogolla et al. 2014 | |||||
Clonazepam |
![]() |
Circling ![]() OF, EPM activity = Fear memory ![]() |
Han et al. 2014 | ||||
Allopregnanolone | EPM arm entries ![]() |
Kazdoba et al. 2016 | |||||
Ganaxolone |
![]() ![]() |
= | = | OF, EPM activity ![]() |
|||
L-838,417 | α2,3 subunit-selective positive allosteric modulator of GABAA receptors |
![]() |
Fear memory (short and long term)
![]() |
Han et al. 2014 | |||
Zolpidem | α1 subunit-selective positive GABAA modulator |
![]() |
Fear memory (only short term) ![]() |
||||
R-baclofen | selective GABAB receptor agonist |
![]() |
![]() |
![]() |
Silverman et al. 2015 | ||
monoaminergic | Risperidone | Qualitatively atypical
antipsychotic (5HT1A,B,D,5A,6,7 antagonist, 5HT2A,B,C inverse agonist, D1,2,4,5 antagonist, D3 inverse agonist, α1A,B, 2A,B antagonist, H1,2 inverse agonist) |
= |
![]() |
Gould et al. 2011 | ||
= | EPM = | Chadman 2011 | |||||
Probabilistic learning ![]() |
Amodeo et al. 2014 | ||||||
Fluoxetine | SERT blocker |
![]() |
= | Gould et al. 2011 | |||
![]() |
EPM = | Chadman 2011 | |||||
Buspirone | 5HT1A receptor partial-agonist |
![]() |
= | Gould et al. 2011 | |||
M100907 | 5HT2A antagonist | Probabilistic learning ![]() |
Amodeo et al. 2014 | ||||
![]() |
Amodeo et al. 2016a and b | ||||||
Citalopram | selective serotonin reuptake inhibitor (SSRI) | Tail suspension ![]() |
Crowley et al. 2005 | ||||
Dietary tryptophan | 5HT precursor |
![]() |
= | = | Zhang et al. 2015 | ||
D-amphetamine | Psychostimulant, acting via DA-ergic enhancement in the mesolimbic circuit |
![]() ![]() |
![]() |
Silverman et al. 2013 | |||
3,4-Methylenedioxym ethamphetamine (MDMA, ecstasy) | Psychostimulant, presynaptic releasing agent of serotonin, norepinephrine, and dopamine | Locomotor activity = | Onaivi et al. 2011 | ||||
metamphetamine | Psychostimulant, full agonist of trace amine-associated receptor 1 (TAAR1) | ||||||
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) | Neurotoxin destroying dopaminergic neurons | ||||||
(−)-trans-Δ9-tetrahydrocannabi nol | partial agonist activity at the cannabinoid receptor CB1 | Spontaneous wheel running ![]() |
|||||
Acetaminophen (paracetamol) | cannabinoid CB(1) receptor-mediated inhibition of serotonin (5-HT) transmission in the frontal cortex, 5HT agonism |
![]() |
= | Gould et al. 2012 | |||
Atomoxetine | noradrenergic reuptake inhibitor | Fear memory ![]() |
Stapley et al. 2013 | ||||
cholinergic | Oxotremorine | Muscarinic acetylcholine receptor (mAChR) agonist |
![]() |
![]() |
Amodeo et al. 2014 | ||
Nicotine | nicotinic acetylcholine receptor (nAChR) agonist |
![]() |
![]() |
OF activity ![]() |
Wang L et al. 2015 | ||
Donepezil | (AchEI) Acetylocholinester ase inhibitor |
![]() ![]() |
Rigidity in T-maze and jammed running wheel
![]() |
Karvat and Kimchi 2014 | |||
other pathways | Chronic intranasal oxytocin | Neuropeptide, OXTR agonist |
=![]() |
= | Juvenile social interaction = Fear memory = |
Bales et al. 2014 | |
Rapamycin | mTORC1 inhibitor |
![]() ![]() |
= | Burket et al. 2014 | |||
histidine, lysine, threonine diet | mTORc1 inhibition | = |
![]() |
Wu et al. 2016 | |||
Sodium butyrate | HDAC inhibitor |
![]() |
= |
![]() |
Kratsman et al. 2016 | ||
SR1078 | retinoic acid receptor-related orphan receptor α (RORα) agonist |
![]() |
![]() |
Wang et al 2016 | |||
GW7647 | Peroxisome proliferator-activated receptor agonist |
![]() |
![]() |
D’Agostino et al. 2015 | |||
sgp130Fc | IL-6 trans-signaling blocker |
![]() |
![]() |
Wei et al. 2016c |
soc appr – social approach in the three chambered apparatus
soc novelty – preference for novel mouse in the third phase of three chambered apparatus social approach test
soc sniffing – either during social approach test in the three chambered apparatus or in close dyadic interaction
MWM – Morris Water Maze
OF – Open Field test
EPM – Elevated Plus Maze